Our team is a rare combination of technology entrepreneurs, prominent scientists and investment experts, who are also active leaders of the community of more than 3,000 founders of medtech projects from the BRICS markets who have raised more than 30 unicorns and hundreds of successful companies.
About Us
Our team is a rare combination of technology entrepreneurs, prominent scientists and investment experts, who are also active leaders of the community of more than 3,000 founders of medtech projects from the BRICS markets who have raised more than 30 unicorns and hundreds of successful companies.
Our Focus
We invest capital and expertise in talented teams and exciting science and technology.
We invest capital and expertise in talented teams and exciting science and technology.
Our focus
Healthcare costs continue to grow at a rapid pace. Genome Capital believes that now is the right time to invest in:
Healthcare costs continue to grow at a rapid pace. Genome Capital believes that now is the right time to invest in:
Robotic Medical devices
AI diagnostic
Telemedicine
NeuroTech
Bioimplants
Robotic Medical devices
AI diagnostic
Telemedicine
NeuroTech
Bioimplants
That can expand the foundations of medical practice, improve the quality of life and provide high returns for our investors.
That can expand the foundations of medical practice, improve the quality of life and provide high returns for our investors.
Impact
Impact
We believe that high financial and societal returns can coexist. More than 5 bn people in emerging markets have limited access to medical services due to shortage of doctors in the region, lack of good infrastructure, and high cost of services and medicines. New technologies in Life Science, IT and Robotics can change the rules of the game!
We believe that high financial and societal returns can coexist. More than 5 bn people in emerging markets have limited access to medical services due to shortage of doctors in the region, lack of good infrastructure, and high cost of services and medicines. New technologies in Life Science, IT and Robotics can change the rules of the game!
Our Team
Sveta Gavrilova
Managing Partner
12 years in HealthTech VC & PE, incl 7 years in Rusnano ($500m AUM, 8 exits, 1 unicorn)
7 years in KPMG audit
Principal of 3,000-member global tech founders' communities
Graduated in Economics & Law (MSU, MSAL)
Founders Institute: VC fund manager program (USA); ACCA prof (UK)